Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Recent Patents on Anti-Cancer Drug Discovery|October 24, 2019
Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma TreatmentRomeo G MihăilăRecent Patents on Anti-Cancer Drug Discovery|May 4, 2022
Venetoclax in Acute Myeloid LeukemiaRomeo G MihăilăRecent Patents on Anti-Cancer Drug Discovery|September 28, 2020
Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in OncohematologyRomeo G MihăilăRecent Patents on Anti-Cancer Drug Discovery|April 1, 2014
Could resveratrol be a useful drug for the treatment of malignant hemopathies?Romeo G MihăilăBiomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 26, 2019
Thrombin generation is increased in patients with <i>Clostridium difficile</i> colitis - a pilot studyRomeo G Mihăilă, Crina Cătană, Ariela L Olteanu, et al.British Journal of Haematology|April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patientsAdrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.American Journal of Hematology|October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patientsAdrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.Pageof 1